<?xml version="1.0" encoding="UTF-8"?>
<p>There are several concerns about the use of convalescent plasma therapy for COVID-19 patients. Transfusion of plasma may cause transfusion-related adverse events, including minor adverse events such as fever, nausea, allergic reactions, transmission of blood-borne pathogens, and some severe adverse events such as transfusion-related acute lung injury (TRALI), transfusion-associated circulatory overload (TACO), and antibody-dependent enhancement (ADE) [
 <xref rid="B10" ref-type="bibr">10</xref>
 <xref rid="B30" ref-type="bibr">30</xref>].
</p>
